Innoveren Scientific Inc. (IVRN)
OTCMKTS
· Delayed Price · Currency is USD
0.0004
-0.0003 (-42.86%)
At close: Jan 14, 2026
Innoveren Scientific Company Description
Innoveren Scientific Inc., a medical bioscience company that develops technology in regenerative medicine for limb salvage.
It is also developing immunotherapies for ovarian cancer, pancreatic cancer, and mesothelioma. The company was formerly known as H-CYTE, Inc. and changed its name to Innoveren Scientific Inc. in July 2023.
The company is headquartered in Tampa, Florida.
Innoveren Scientific Inc.
| Country | United States |
| Industry | Biotechnology |
| Sector | Healthcare |
| Employees | 2 |
| CEO | Michael Yurkowsky |
Contact Details
Address: 201 East Kennedy Blvd Tampa, Florida 33602 United States | |
| Phone | 844 633 6839 |
| Website | innoverenscientific.com |
Stock Details
| Ticker Symbol | IVRN |
| Exchange | OTCMKTS |
| Stock Type | Common Stock |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| ISIN Number | US4041243076 |
| SIC Code | 3842 |
Key Executives
| Name | Position |
|---|---|
| Michael W. Yurkowsky | Chief Executive Officer and Director |
| Dr. Tanya Rhodes Ph.D. | Chief Scientific Officer |